Drugs / [C-11]-CS1P1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07462507 | Apr 2026 → Jun 2031 expected | metastatic malignant neoplasm in the brain | Washington University School of Medicine | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [C-11]-CS1P1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07462507 ↗ |
| Modality | Diagnostic / imaging agent | “is an S1P1 PET imaging agent.” NCT07462507 ↗ |
| Route | Intravenous | “following intravenous administration of \[C-11\]-CS1P1” NCT07462507 ↗ |